SEP 07, 2016 10:30 AM PDT

Diagnostic Development and Laboratory Response to Infectious Disease Outbreaks

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Assistant Professor, Pathology & Immunology, and Pediatrics, Baylor College of Medicine
    Biography
      Paula A Revell PhD D(ABMM) obtained her bachelors degrees at Washington University in St Louis, and her PhD from the Washington University School of medicine where studied the bacterial pathogenesis of Yersinia enterocolitica in Dr Virginia Miller's laboratory. Dr Revell's post-doctoral studies included work on tumor immunology in Dr Timothy Ley's laboratory followed by a fellowship in Medical and Public Health Laboratory Microbiology at Washington University, Barnes-Jewish Hospital, and St. Louis Children's Hospital, Department of Pathology & Immunology under the direction of Drs Mike Dunne and Greg Storch. Dr Revell is currently an assistant professor of Pathology and Pediatrics at Baylor College of Medicine and Clinical liaison in the medical microbiology laboratories at Texas Children's Hospital. Her former positions include assistant professor at University of Texas Southwestern School of Medicine, departments of pediatrics and pathology, Director of Medical Microbiology at Children's Medical Center of Dallas, and Director of Medical Microbiology laboratories at Texas Children's Hospital.
      Dr Revell has a strong interest in pediatric microbiology with a focus on molecular diagnostics, as well as an interest in the evolution of gram negative antimicrobial resistance.

    Abstract:

    The field of infectious disease diagnostics is ever changing with both newly identified infections such as SARS, Ebola, and Zika virus as well as yearly epidemics and potential for pandemic with pathogens that constantly circulate among us such as Influenza.  The ability of the laboratory to quickly respond to outbreak situations is critical.  This talk will provide an overview of the processes involved in developing, validating and implementing new diagnostic tests in the time sensitive setting of infectious disease outbreaks.


    Show Resources
    You May Also Like
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    MAY 02, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 02, 2018 08:00 AM PDT
    Immunohistochemistry protocols, which utilize antibodies to visualize proteins in tissue sections, have many steps that need optimized to prevent non-specific background effects, artifacts, o...
    Loading Comments...
    Show Resources